FDA clears Stryker’s total knee for Mako robot-assisted surgery device

Stryker_StrykerMakoLogos_WEBStryker (NYSE:SYK) said yesterday that it won 510(k) clearance from the FDA for a total knee tool for the Mako Surgical robot-assisted surgery platform it bought in 2013.

Stryker now has Mako-compatible offerings for total and partial knee replacement and total hip replacement, the company said.

“The ability to include a Mako total knee application with our market leading Triathlon total knee system represents a key milestone in reconstructive surgery,” Stryker Orthopaedics president David Floyd said in prepared remarks. “We are excited about the opportunity to transform orthopaedics by furthering the growth of robotic-arm assisted surgery, and by enhancing the surgeon and patient experience.”

Stryker said it plans to have the total knee option on the U.S. market by the end of the year in a limited release.


About Peter Coffaro 1426 Articles
A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the medical device industry. As a District Sales Manager for Stryker Orthopaedics, Peter was responsible for managing and directing a regional sales force to achieve sales and profit goals within the Rocky Mountain region. Previously, he was the Director of Sales & Marketing for Amp Orthopedics. In this role, Peter was responsible for planning, developing, and leading all sales and marketing initiatives. Peter is a former orthopedic distributor in the Pacific Northwest. He has also worked with DePuy Orthopaedics as well as Zimmer, and held positions in sales, sales training, and sales management. Peter has an extensive background in organizational development, business development, sales management, negotiating and P&L management. Peter holds a B.S. degree in Biology from Northern Illinois University.

Be the first to comment

Leave a Reply

Your email address will not be published.